Aeolus Pharmaceuticals, Inc. (AOLS)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Aug 18, 2025
Aeolus Pharmaceuticals Market Cap
Aeolus Pharmaceuticals has a market cap or net worth of $15.21 thousand as of September 8, 2025. Its market cap has decreased by -95.73% in one year.
Market Cap
15.21K
Enterprise Value
n/a
Revenue
771.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 2, 1996, Aeolus Pharmaceuticals's market cap has decreased from 132.72M to 15.21K, a decrease of -99.99%. That is a compound annual growth rate of -26.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 15.21K | - |
| Dec 28, 2022 | 15.21K | 9,905.92% |
| Dec 27, 2021 | 152.00 | -99.96% |
| Dec 31, 2020 | 355.88K | 192.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.85M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |
| American Oncology Network | 353.52M |